Bearss, D J <br/><br/>
Telomere maintenance mechanisms as a target for drug development.  [electronic resource] 

 -  Oncogene  Dec 2000 
 - 6632-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1204092  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracenes--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Drug Delivery Systems<br/>Drug Design<br/>Glycoside Hydrolases--metabolism<br/>Humans<br/>Neoplasms--enzymology<br/>Oligonucleotides, Antisense--therapeutic use<br/>Perylene--analogs & derivatives<br/>Piperidines--pharmacology<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>RNA<br/>RNA, Long Noncoding<br/>RNA, Untranslated--antagonists & inhibitors<br/>Reverse Transcriptase Inhibitors--pharmacology<br/>Tankyrases<br/>Telomerase--antagonists & inhibitors<br/>Telomere--chemistry